世界のポイントオブケア診断市場動向及び予測（～2018）...市場調査レポートについてご紹介

Table of Contents

1Introduction (Page No. – 25)
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Market Share Estimation
1.6.4 Key Data Points From Secondary Sources
1.6.5 Key Data Points From Primary Sources
1.6.6 Assumptions

2 Executive Summary (Page No. – 37)

3 Premium Insights (Page No. – 42)
3.1 Product Growth Matrix
3.2 Life Cycle Analysis, By Geography
3.3 Market Chasm Analysis

4 Market Overview (Page No. – 47)
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.3.1 Point of Care Diagnostics Market By Product
4.3.2 Point of Care Diagnostics Market By Prescription Mode
4.3.3 Point of Care Diagnostics Market By End User
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Huge prevalence of infectious diseases in developing countries
4.4.1.2 Increasing incidences of lifestyle diseases (cardiac diseases and diabetes)
4.4.1.3 Rising usage of home-based POC devices is improving patient compliance
4.4.1.4 Private investments and venture funding to support development of new products
4.4.1.5 Growing government support to magnify the adoption of POC devices
4.4.1.6 Expansion of therapeutic horizon
4.4.1.7 Fostering approval of novel immunoassay techniques
4.4.1.8 Technological advancements
4.4.1.9 Large number of awareness campaigns/ conferences in developing countries
4.4.1.10 Decreasing number of technicians available in central labs
4.4.2 Restraints
4.4.2.1 Lack of alignment with definitive central lab methods
4.4.2.2 Disadvantages of POC testing over central lab methods
4.4.2.3 Recall of leading glucose monitoring devices
4.4.2.4 Reluctance to change the existing treatment practices
4.4.3 Oppurtunities
4.4.3.1 Emerging markets(India, China, and Brazil)
4.4.3.2 Healthcare decentralization
4.4.3.3 Miniaturization of POC testing devices
4.4.4 Challenges
4.4.4.1 Growing price-cutting measures
4.4.4.2 Stringent and time-consuming regulatory policies
4.4.5 Burning Issues
4.4.5.1 Unfavorable reimbursement scenario in many countries
4.4.5.2 High cost of POC devices
4.4.6 Winning Imperatives
4.4.6.1 Strategy of geographic expansion in emerging markets
4.4.6.2 Strategy of development of low-cost POC devices
4.4.6.3 Strategy of development of multi-assay POC devices

5 Industry Trends (Page No. – 68)
5.1 Introduction
5.2 Value Chain Analysis
5.3 Supply Chain Analysis
5.3.1 Key Influencers:
5.4 Industry Trends
5.4.1 Standardization Of Poc Testing Devices
5.4.2 Acquisition Of Small Players
5.4.3 Growing Focus On Microfluidics-Based Poc Devices
5.4.3.1 Microfluidic technology based lab-on-a-chip devices will bring laboratory testing to patient’s finger tips
5.5 Pricing And Cost Analysis
5.6 Porter’s Five Forces Analysis
5.6.1 Threat From New Entrants
5.6.2 Threat From Substitutes
5.6.3 Bargaining Power Of Suppliers
5.6.4 Bargaining Power Of Buyers
5.6.5 Intensity Of Competitive Rivalry
5.7 PEST Analysis
5.7.1 Political Factors
5.7.2 Economic Factors
5.7.3 Social Factors
5.7.4 Technological Factors
5.8 Strategic Benchmarking
5.8.1 Technology Integration & Product Enhancement
5.8.2 Entry Into Tumor/Cancer Testing Market

6 Point-Of-Care Diagnostics Market, By Product (Page No. – 89)
6.1 Introduction
6.2 Glucose Monitoring Kits Market
6.2.1 Glucose Monitoring Strips Market
6.2.2 Glucose Monitoring Devices Market
6.2.3 Lancets Market
6.3 Cardiac Markers Market
6.4 Infectious Dieases Testing Kits Market
6.4.1 Influenza Testing Kits Market
6.4.2 Hiv Testing Kits Market
6.4.3 Hepatitis b Testing Kits Market
6.4.4 Sexually-Transmitted Diseases (STDS) testing Kits Market
6.4.5 Tuberculosis (TB) Testing Kits Market
6.4.6 Tropical Diseases Testing Kits Market
6.5 Coagulation Monitoring Kits Market
6.5.1 Prothrombin Time (PT/INR) Testing Kits Market
6.5.2 Activated Clotting Time (ACT/APTT) Testing Kits Market
6.6 Pregnancy And Fertility Testing Kits Market
6.6.1 Pregnancy Testing Kits Market
6.6.2 Fertility Testing Kits Market
6.7 Blood Gas/Electrolytes Testing Kits Market
6.8 Tumor/Cancer Markers Market
6.8.1 Urinalysis Testing Kits Market
6.9 Cholesterol Test Strips Market
6.10 Hematology Testing Kits Market
6.10.1 Hemoglobin Assay Kits Market
6.10.2 Hemostasis Assay Kits Market
6.11 Food Pathogens Testing Kits Market
6.12 Drugs Of Abuse Testing Kits Market
6.13 Fecal Occult Testing Kits Market
6.14 Other Testing Kits Market

7 Point-Of-Care Diagnostics Market, By Prescription Mode (Page No. – 143)
7.1 Introduction
7.2 Prescription-Based Testing Kits Market
7.3 Otc Testing Kits Market

8 Point-Of-Care Diagnostics Market, By End User (Page No. – 151)
8.1 Introduction
8.2 Patient Professional Monitoring Kits Market
8.2.1 Inpatient Monitoring Kits Market
8.2.2 Outpatient Monitoring Kits Market
8.2.3 Special Areas Monitoring Kits Market
8.2.4 Other Areas Professional Monitoring Kits Market
8.3 Patient Self-Monitoring Kits Market

9 Point-Of-Care Diagnostics Market, By Geography (Page No. – 163)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest Of Europe (ROE)
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest Of Asia-Pacific
9.5 Rest Of The World (Row)
9.5.1 Latin America
9.5.2 Africa
9.5.3 Middle East

10 Competitive Landscape (Page No. – 307)
10.1 Overview
10.2 Market Share Analysis, Poc Diagnostics Market (Excluding Blood Glucose Monitoring Kits)
10.3 Market Share Analysis, Blood Glucose Monitoring Kits Market
10.4 Competitive Situation And Trends
10.5 New Product Launches
10.6 Agreements, Partnerships, Collaborations, & Joint Ventures
10.7 Mergers And Acquisitions
10.8 Expansions
10.9 Other Developments

11 Company Profiles (Page No. – 342)
11.1 Abaxis, Inc.
11.1.1 Overview
11.1.2 Financials
11.1.3 Products & Services
11.1.4 Strategy
11.1.5 Developments
11.2 Abbott Laboratories, Inc.
11.2.1 Overview
11.2.2 Financials
11.2.3 Products & Services
11.2.4 Strategy
11.2.5 Developments
11.2.6 Swot Analysis
11.2.7 MNM View
11.3 Alere, Inc.
11.3.1 Overview
11.3.2 Financials
11.3.3 Products & Services
11.3.4 Strategy
11.3.5 Developments
11.3.6 Swot Analysis
11.3.7 MnM view
11.4 Bayer Healthcare ag (A Subsidiary Of Bayer ag)
11.4.1 Overview
11.4.2 Financials
11.4.3 Products & Services
11.4.4 Key Strategy
11.4.5 Developments
11.5 Beckman Coulter, Inc. (A Subsidiary Of Danaher Corporation)
11.5.1 Overview
11.5.2 Financials
11.5.3 Products & Services
11.5.4 Strategy
11.5.5 Developments
11.6 Becton, Dickinson And Company
11.6.1 Overview
11.6.2 Financials
11.6.3 Products & Services
11.6.4 Strategy
11.6.5 Developments
11.7 Johnson & Johnson
11.7.1 Overview
11.7.2 Financials
11.7.3 Products & Services
11.7.4 Strategy
11.7.5 Developments
11.8 Nipro Diagnostics, Inc. (A Subsidiary Of Nipro Corporation)
11.8.1 Overview
11.8.2 Financials
11.8.3 Products & Services
11.8.4 Strategy
11.8.5 Developments
11.9 Roche Diagnostics Limited (A Subsidairy Of F. Hoffmann-La Roche Ltd)
11.9.1 Overview
11.9.2 Financials
11.9.3 Products & Services
11.9.4 Strategy
11.9.5 Developments
11.9.6 Swot Analysis
11.9.7 MnM View
11.1 Siemens Healthcare (A Division Of Siemens ag)
11.10.1 Overview
11.10.2 Financials
11.10.3 Products & Services
11.10.4 Strategy
11.10.5 Developments